Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


European Commission approves Wyost (denosumab) and Jubbonti (denosumab) which are the first and only biosimilars of denosumab in Europe – Sandoz

Written by | 30 May 2024

Sandoz, the global leader in generic and biosimilar medicines, announced that the European Commission (EC) has granted marketing authorization for Wyost (C) and Jubbonti (denosumab), the first and… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.